201 related articles for article (PubMed ID: 2370888)
1. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.
Kennington AS; Hill CR; Craig J; Bogardus C; Raz I; Ortmeyer HK; Hansen BC; Romero G; Larner J
N Engl J Med; 1990 Aug; 323(6):373-8. PubMed ID: 2370888
[TBL] [Abstract][Full Text] [Related]
2. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.
Campbell WW; Ostlund RE; Joseph LJ; Farrell PA; Evans WJ
Horm Metab Res; 2001 Jan; 33(1):44-51. PubMed ID: 11280715
[TBL] [Abstract][Full Text] [Related]
3. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat.
Kawa JM; Przybylski R; Taylor CG
Exp Biol Med (Maywood); 2003 Sep; 228(8):907-14. PubMed ID: 12968062
[TBL] [Abstract][Full Text] [Related]
4. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.
Jung TS; Hahm JR; Kim JJ; Jung JH; Kang MY; Moon SW; Lee KW; Kim HC; Lee JD; Kim JH; Kim DR; Chung SI
Yonsei Med J; 2005 Aug; 46(4):532-8. PubMed ID: 16127779
[TBL] [Abstract][Full Text] [Related]
5. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.
Sun TH; Heimark DB; Nguygen T; Nadler JL; Larner J
Biochem Biophys Res Commun; 2002 May; 293(3):1092-8. PubMed ID: 12051772
[TBL] [Abstract][Full Text] [Related]
6. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes.
Suzuki S; Kawasaki H; Satoh Y; Ohtomo M; Hirai M; Hirai A; Hirai S; Onoda M; Matsumoto M; Hinokio Y
Diabetes Care; 1994 Dec; 17(12):1465-8. PubMed ID: 7882818
[TBL] [Abstract][Full Text] [Related]
7. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.
Asplin I; Galasko G; Larner J
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5924-8. PubMed ID: 8392181
[TBL] [Abstract][Full Text] [Related]
8. D-chiro-inositol metabolism in diabetes mellitus.
Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346
[TBL] [Abstract][Full Text] [Related]
9. Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.
Ortmeyer HK; Bodkin NL; Lilley K; Larner J; Hansen BC
Endocrinology; 1993 Feb; 132(2):640-5. PubMed ID: 8425483
[TBL] [Abstract][Full Text] [Related]
10. Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus.
Hong JH; Jang HW; Kang YE; Lee JH; Kim KS; Kim HJ; Park KR; Ku BJ
Dis Markers; 2012; 33(4):193-9. PubMed ID: 22960342
[TBL] [Abstract][Full Text] [Related]
11. Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation.
Stull AJ; Thyfault JP; Haub MD; Ostlund RE; Campbell WW
Metabolism; 2008 Nov; 57(11):1545-51. PubMed ID: 18940392
[TBL] [Abstract][Full Text] [Related]
12. D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance.
Larner J
Int J Exp Diabetes Res; 2002; 3(1):47-60. PubMed ID: 11900279
[TBL] [Abstract][Full Text] [Related]
13. Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats.
Fonteles MC; Almeida MQ; Larner J
Horm Metab Res; 2000 Apr; 32(4):129-32. PubMed ID: 10824707
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and urinary excretion of sodium in hypertensive patients with non-insulin dependent diabetes mellitus.
Singh SK; Sarkar D; Agrawal JK
J Assoc Physicians India; 1999 Jul; 47(7):709-11. PubMed ID: 10778592
[TBL] [Abstract][Full Text] [Related]
15. The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.
Chang HH; Choong B; Phillips AR; Loomes KM
Exp Biol Med (Maywood); 2015 Jan; 240(1):8-14. PubMed ID: 25060739
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS method for the quantification of myo- and chiro-inositol as the urinary biomarkers of insulin resistance in human urine.
Kim BH; Park JY; Jang JB; Moon DC
Biomed Chromatogr; 2012 Apr; 26(4):429-33. PubMed ID: 21830227
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Wu Y; Ouyang JP; Zhou YF; Wu K; Zhao DH; Wen CY
Sheng Li Xue Bao; 2004 Aug; 56(4):539-49. PubMed ID: 15322693
[TBL] [Abstract][Full Text] [Related]
18. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.
Farese RV; Standaert ML; Yamada K; Huang LC; Zhang C; Cooper DR; Wang Z; Yang Y; Suzuki S; Toyota T
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11040-4. PubMed ID: 7972005
[TBL] [Abstract][Full Text] [Related]
19. Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.
Villeneuve MC; Ostlund RE; Baillargeon JP
Metabolism; 2009 Jan; 58(1):62-8. PubMed ID: 19059532
[TBL] [Abstract][Full Text] [Related]
20. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
Vaag A
Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]